Alembic Pharmaceuticals Ltd.
Snapshot View

523.00 -3.90 ▼-0.7%

09 February 2023, 01:56:59 PM
Volume: 26,761

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alembicpharmaceuticals.com
Market Cap 10,307.77 Cr.
Enterprise Value(EV) 10,970.22 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 11.44 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 45.84 Trailing Twelve Months Ending 2022-12
Industry PE 30.86 Trailing Twelve Months Ending 2022-12
Book Value / Share 277.23 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.89 Calculated using Price: 524.40
Dividend Yield 1.91 Period Ending 2022-03
No. of Shares Subscribed 19.66 Cr. 196,563,124 Shares
FaceValue 2
Company Profile
The company is principally engaged in the manufacturing and selling of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company presents an extensive range of branded and generic formulations, in compliance with international and national regulations, that cater to diverse therapeutic segments.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.74%
1 Week
-3.32%
1 Month
-6.82%
3 Month
-15.73%
6 Month
-21.21%
1 Year
-30.60%
2 Year
-44.15%
5 Year
-4.08%
10 Year
+606.28%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 39.97 36.24 58.02 23.25 20.42 24.00 26.97 26.91 10.01
Return on Capital Employed (%) 43.54 37.54 65.86 28.87 22.15 22.66 23.30 26.28 11.16
Return on Assets (%) 18.79 18.76 33.75 14.97 12.25 13.15 14.64 17.22 7.27

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 676 885 1,597 1,902 2,220 2,719 3,219 5,067 5,238 5,120
Non Curr. Liab. 94 72 84 94 576 570 1,047 361 162 145
Curr. Liab. 603 684 944 814 1,267 1,664 1,752 1,533 1,831 1,818
Minority Int. 0 0 -1 -29
Equity & Liab. 1,372 1,641 2,626 2,811 4,064 4,952 5,989 6,961 7,230 7,083
Non Curr. Assets 516 750 917 1,317 2,116 2,820 3,526 4,057 4,255 4,253
Curr. Assets 857 891 1,708 1,494 1,948 2,132 2,463 2,904 2,975 2,829
Misc. Exp. not W/O
Total Assets 1,372 1,641 2,626 2,811 4,064 4,952 5,989 6,961 7,230 7,083

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1,863 2,056 3,166 3,135 3,131 3,935 4,606 5,393 5,306 5,662
Other Income 4 12 9 3 35 27 14 87 50 12
Total Income 1,868 2,068 3,175 3,137 3,166 3,962 4,620 5,481 5,356 5,674
Total Expenditure -1,506 -1,661 -2,161 -2,520 -2,516 -3,079 -3,392 -3,913 -4,432 -5,006
PBIDT 362 407 1,014 617 650 883 1,228 1,568 925 668
Interest -10 -4 -5 -5 -3 -18 -27 -16 -18 -43
Depreciation -40 -44 -72 -83 -105 -115 -157 -183 -287 -324
Taxation -75 -76 -216 -122 -120 -157 -199 -253 -104 -47
Exceptional Items -44
PAT 236 283 720 407 421 593 801 1,115 516 254
Minority Interest 0 0 1 28 5
Share Associate 0 -4 -8 -9 0 32 5 -34
Other Related Items
Consolidated Net Profit 236 283 720 403 413 584 829 1,147 521 225
Adjusted EPS 12 15 38 21 22 31 44 58 27 11

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 265 240 172 948 329 312 812 449 1,463 552
Cash Fr. Inv. -67 -81 -256 -307 -486 -884 -756 -732 -839 -372
Cash Fr. Finan. -229 -151 87 -224 -129 503 59 155 -597 -217
Net Change -31 8 3 417 -286 -69 115 -128 27 -37
Cash & Cash Eqvt 16 24 27 439 153 84 199 72 98 61

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 69.78 69.48 69.48 69.48 69.48 69.61 69.61 69.61 69.61
Public 30.22 30.52 30.52 30.52 30.52 30.39 30.39 30.39 30.39
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 08 Feb 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Alembic Pharmaceuticals Limited has informed the Exchange about Transcript
Thu, 02 Feb 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Alembic Pharmaceuticals Limited has informed the Exchange about Link of Recording
Thu, 02 Feb 2023
Appointment
Alembic Pharmaceuticals Limited has informed the Exchange regarding Appointment of Ms Manisha Saraf as Company Secretary & Compliance Officer of the company w.e.f. April 01, 2023.

Technical Scans View Details >>

Wed, 08 Feb 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 6 Months High Decrease in 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.80 -0.6%
Cipla Ltd. 83,886.47 1,024.80 -1.4%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,509.55 +0.5%
Divi's Laboratories Ltd. 74,340.49 2,819.75 +0.7%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,396.90 +0.1%
Torrent Pharmaceuticals Ltd. 52,675.65 1,544.85 -0.8%
Zydus Lifesciences Ltd. 47,993.66 473.10 -0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-12 31.80 1,024.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,509.55 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,819.75 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,396.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,544.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 473.10 -0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-12 3.70 1,024.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,509.55 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,819.75 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,396.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,544.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 473.10 -0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,024.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,509.55 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,819.75 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,396.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,544.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 473.10 -0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,509.55 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,819.75 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,396.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,544.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.10 -0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,509.55 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,819.75 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,396.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,544.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.10 -0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,024.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,509.55 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,819.75 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,396.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,544.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 473.10 -0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.80 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,024.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,509.55 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,819.75 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,396.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,544.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 473.10 -0.2%

FAQ's On Alembic Pharmaceuticals Ltd.

What is Alembic Pharma share price?

Can I buy Alembic Pharma shares now?

What is the Dividend Yield of Alembic Pharma?

What is the Market Cap of Alembic Pharma?

What are the key metrics to analyse Alembic Pharma?

What is the 52 Week High and Low of Alembic Pharma?

What is the trend of Alembic Pharma share price?